The quantitation of T cells by image analysis revealed that infiltration of CD4+ or CD8+ T cells was enhanced by nivolumab treatment in huNOG-FcγR−/− mice, but the degree was largely dependent on the tumor cell lines (Fig. 5). This evidence concerns the gene CD4 and neoplasm.